Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832:
SAYS ACTUAL CONTROLLER WENG XIANDING HAS BEEN PLACED UNDER DETENTION
Shenzhen New Industries Biomedical Engineering's Actual Controller Under Detention
Earlier from Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A
- Shenzhen New Industries Biomedical Engineering: 2025 revenue rose 0.91% to ¥4.58B, with net profit down 11.39% amid strong overseas growth
- Shenzhen New Industries Biomedical Engineering Q1 Net Profit Up 1% Y/Y
- Shenzhen New Industries Biomedical Engineering Co: Revenue up 3.28% in Q3 2025, but net profit down 9.72% as domestic sales declined
- New Industries Biomedical Q3 Net Profit Down 9.7% Y/Y